Login to Your Account



Other News To Note


Wednesday, June 20, 2012
• Coronado Biosciences Inc., of Burlington, Mass., reported that the FDA granted orphan drug status to its biologic CNDO-109 for the treatment of acute myeloid leukemia (AML).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription